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Trypanosoma cruzi is a rare example of an eukaryote that has genes for two threonine proteases: HslVU
complex and 20S proteasome. HslVU is an ATP-dependent protease consisting of two multimeric compo-
nents: the HslU ATPase and the HslV peptidase. In this study, we expressed and obtained speciﬁc antibod-
ies to HslU and HslV recombinant proteins and demonstrated the interaction between HslU/HslV by
coimmunoprecipitation. To evaluate the intracellular distribution of HslV in T. cruzi we used an immuno-
ﬂuorescence assay and ultrastructural localization by transmission electron microscopy. Both techniques
demonstrated that HslV was localized in the kinetoplast of epimastigotes. We also analyzed the HslV/20S
proteasome co-expression in Y, Berenice 62 (Be-62) and Berenice 78 (Be-78) T. cruzi strains. Our results
showed that HslV and 20S proteasome are differently expressed in these strains. To investigate whether a
proteasome inhibitor could modulate HslV and proteasome expressions, epimastigotes from T. cruziwere
grown in the presence of PSI, a classical proteasome inhibitor. This result showed that while the level of
expression of HslV/20S proteasome is not affected in Be-78 strain, in Y and Be-62 strains the presence of
PSI induced a signiﬁcantly increase in Hslv/20S proteasome expression. Together, these results suggest
the coexistence of the protease HslVU and 20S proteasome in T. cruzi, reinforcing the hypothesis that
non-lysosomal degradation pathways have an important role in T. cruzi biology.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Chagas disease is caused by Trypanosoma cruzi and was discov-
ered in 1909 by the Brazilian scientist Carlos Chagas. It is a wide-
spread and important disease in Latin America affecting about 13
million people in Central and South America (World Health
Organization, 2005). The different clinical manifestations in Chagas
disease are determined by the great diversity of T. cruzi strains,
which involve factors related to their genetic, antigenic and bio-
chemical features and tissue tropism and virulence, among other
factors. The main difﬁculty in obtaining a parasitological cure is
the great genetic variability of parasite strains (Brener and Chiari,
1967) and the existence of naturally drug-resistant strains (Filardiioquímica e Biologia Molec-
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evier OA license.and Brener, 1987). Currently, the only medically prescribed drugs
for the treatment of patients with Chagas disease are nifurtimox
and benznidazole.
The parasite genome has been annotated since 2004, providing
new opportunities to study T. cruzi proteases (El-Sayed et al., 2005).
Because these proteases play crucial roles in different metabolic
pathways in T. cruzi, they had been considered as potential drug
targets, especially because this parasite has a complex life cycle.
Among the threonine proteases, ATP-dependent proteases are
an important class that plays essential role in controlling the levels
of key regulatory proteins and in the elimination of abnormal poly-
peptides. In eukaryotes the 20S proteasome is a threonine protease
characterized as a multicatalytic protease with chymotrypsin-like,
trypsin-like and peptidylglutamyl-peptide hydrolase activities that
can interact with regulator complexes such as PA700, PA28 and
PA200. Proteasomes are considered both ubiquitous and essential
in eukaryotes (Kim et al., 2011), whereas most bacteria possess
heat-shock genes denominated hslV and hslU, whose gene products
are a multimeric protease arranged in a two-layered ring and an
ATPase.
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protease. The HslV subunit is a homolog of the b-subunit of 20S
proteasome. It forms a barrel-shaped dodecameric complex by
stacking two hexameric rings of identical HslV subunits, and each
of the HslV subunits contains an N-terminal Thr (Thr1) active site
for proteolysis (Chuang et al., 1993; Gille et al., 2003; Rohrwild
et al., 1996). The hexameric HslU ATPase, which belongs to the
AAA + family of ATPases, binds to either one or both ends of HslV
dodecamer to form an HslVU complex (Bochtler et al., 2000; See-
mulle et al., 1995; Seong et al., 2000; Sousa et al., 2000; Wang
et al., 2001).
In the HslVU complex, the central pores of HslU and HslV are
aligned so that HslU transfers substrate polypeptide chains
through the pores into the inner proteolytic chamber of HslV, a
process also dependent of ATP (Seong et al., 2002).
Li et al. (2008) demonstrated that Trypanosoma brucei expresses
an enzymatically active ATP-dependent HslVU homolog located in
the mitochondrion. Similar results have been described for Plasmo-
dium (Mordmüller et al., 2006; Ramasamy et al., 2007; Tschan
et al., 2010). However, despite the fact that HslVU genes had al-
ready been identiﬁed in T. cruzi (Couvreur et al., 2002; Gille
et al., 2003), little is known about the function of HslVU in this par-
asite. In the present study, we describe cloning, expression and
puriﬁcation of T. cruzi HslV and HslU recombinant proteins and
produce polyclonal antibodies to perform intracellular localization.
We also demonstrate that HslV and 20S proteasome expression
proﬁles differ between the T. cruzi strains analyzed and are modu-
lated by the proteasome inhibitor PSI. Furthermore, we show the
immunoprecipitation of HslVU components.2. Materials and methods
2.1. Parasites
Four T. cruzi strains were used in this study. Epimastigotes from
Be-62, Be-78, Y and Dm28c strains were grown in LIT medium as
described (Camargo, 1964) for 3 days. For experiments with the
protease inhibitor PSI (Proteasome Sintetyc Inhibitor), parasites
were grown in LIT medium (Camargo, 1964), supplemented with
30 nM PSI at 28 C. The control group was grown under 50 lM of
DMSO without PSI.2.2. Production of polyclonal antiserum andWestern blot assay T. cruzi
HslV (TcHslV) and HslU (TcHslU) were expressed using the
Invitrogen Gateway system as described by Cardoso et al.
(2011). The coding regions of HslV (Tc00.1047053510719.260)
and HslU (Tc00.1047053506739.50) were ampliﬁed with the prim-
ers TcHslVF (50GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGATG
TTTCGTCGTATCGCTCGACACA30), TcHslVR (50GGGGACCACTTTGTAC
AAGAAAGCTGGGTCCTTATTATTCGCTTTTCTTCTCTTCTGAA30), TcHs-
lUF (50GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGCGTCGTGCG
ACTGTCT30) and TcHslUR (50GGGGACCACTTTGTACAAGAAAGCTG
GGTCCTAAAGAATGAACTTCTTAATATCCACCT30). The recombinant
proteins were puriﬁed by electroelution. Brieﬂy, insoluble proteins
were fractioned onto SDS-PAGE 12% and precipitated by KCl
100 mM. The spots corresponding to TcHslV and TcHslU proteins
were excised and eluted in a dialysis membrane at 50 V for 2 h.
Three micrograms of puriﬁed recombinant TcHslV and TcHslU
were subjected to SDS-PAGE. The spot corresponding were excised
and reduced and alkylated by 50 mM DTT and 200 mM iodoaceta-
mide, respectively. Puriﬁed sample (1 ll) was submitted to mass
spectrometric analyses on LCMS-IT-TOF (Shimadzu), at Universid-
ade Federal de Ouro Preto, MG, Brazil. The data were submitted tothe search for identity in the database of T. cruzi GeneDB using
MASCOT software.
Mice were used to produce polyclonal antisera against the re-
combinant HslV and HslU proteins. They were immunized with
an i.p. injection of 20 lg of the appropriate antigen in Freund’s
complete adjuvant (FCA; Sigma) for the ﬁrst inoculation, and with
20 lg of the recombinant protein in Freund’s incomplete adjuvant
(Sigma) for three booster injections, administered at two-week
intervals. Antisera were obtained ﬁve days after the last booster
injection.
Animal experiments were approved by the institutional review
board of the Oswaldo Cruz Foundation (CEUA/FIOCRUZ, Protocol
number P-0434/07).
For Western blot analysis, about 20 lg of total cellular extract
from each strain studied were subjected to SDS-PAGE and then
blotted onto nitrocellulose membranes. The membranes were
blocked with 5% fat-free milk in TBS buffer (150 mM NaCl,
10 mM Tris–HCl, pH 8.0) supplemented with 0.1% Tween-20 and
incubated in the presence of an antiserum against HslV and HslU
of T. cruzi. The result was detected with NBT/BCIP (Promega).
2.3. Preparation of T. cruzi protein extracts
Cells were harvested, washed and lysed by sonication in 20S
buffer (25 mM Tris–HCl, pH 7.5, 10% glycerol, 1 mM DTT, 1 mM
EDTA, 1% Np-40, 10 lM of the following protease inhibitors TLCK,
TPCK, NEM, PMSF). After centrifugation at 10,000g for 15 min,
concentration of soluble proteins was determined by QuantiPro™
BCA Assay Kit as described by the manufacturer (Sigma Aldrich).
2.4. Expression analysis of T. cruzi HslV and proteasome
Fiﬁty micrograms of protein were fractioned onto SDS-PAGE
12%. The gel was transferred to a PVDF membrane at 25 V for 2 h
at 4 C and the membranes were blocked with 5% fat-free milk in
TBS buffer supplemented with 0.3% Tween-20. Determination of
20S proteasome and HslV expression was performed by incubation
of the membrane with polyclonal anti-T. cruzi a7 proteasome sub-
unit and anti-T. cruzi HslV antibodies, respectively. Secondary anti-
body incubation was performed using antibodies against mouse
IgG (1:10,000 dilution; Bio-Rad) for HslV and a7 proteasome sub-
unit and antibodies against rabbit IgG (1:5000 dilution) for HSP70.
The result was detected with NBT/BCIP (Promega).
The results were normalized by incubating the same membrane
with an antibody against the T. cruzi HSP70 (Murta et al., 2008) as a
loading control. Membranes were scanned and protein bands were
analyzed using Quantity one 4.4.1(Bio-Rad) software. The density
of the immunoreactive bands was divided by the density of the
HSP70 band. The results are expressed in densitometric units.
2.5. Immunoprecipitation
Anti-HslV mouse serum or pre-immune mouse serum were
incubated with 50 ll of protein G-Sepharose (Sigma) in 200 ll of
PBS 1x and BSA 1 mg/ml buffer for 2 h at room temperature. Sam-
ples were washed twice with PBS 1x. The resin was collected by
centrifugation for 1 min at 600g. The antibody was cross-linked
to the resin as described (Rigaut et al., 1999).
A total of 1 mg of epimastigotes protein extract from T. cruzi Y
strain was incubated with antibody-coupled protein G-Sepharose
resin overnight at 4 C. The resin was washed three times with na-
tive lysis solution (0.02 MTris–HCl, pH8.0; 0.3 MNaCl; 10%Glicerol;
0,1% NP-40 1 mM PMSF; 10 lM E-64) and the immunoprecipitate
was eluted by 50 ll of 200 mMglicine, pH 2.5, collected by centrifu-
gation for 1 min at 600g andneutralizedwith20 ll of Tris–HCl 1 M
pH 9.5. The eluates from the columnwere loaded in a SDS-PAGE gel
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bodies as described above.
2.6. Immunoﬂuorescence assay
Epimastigotes of Dm28c and Y strains were washed and resus-
pended in PBS at a density of 107 cells/ml. The cells were adhered
to poly-L-lysine-coated slides for 20 min at room temperature,
ﬁxed with 4% paraformaldehyde for 10 min, washed in PBS and
then treated with 50 mM NH4Cl for another 10 min. Fixed cells
were permeabilized with 0.1% Triton X-100 in PBS for 2 min and
then blocked by overnight incubation with 1.5% bovine serum
albumin (BSA) in PBS. The cells were then incubated for 1 h with
polyclonal antiserum at a dilution of 1:100 (anti-HslV). The sam-
ples were washed and incubated for 1 h with Alexa 488-conju-
gated goat anti-mouse antibody (Sigma) diluted at 1:500, as well
as with DAPI (0.3 lg/ml). Stained slides were observed with an epi-
ﬂuorescence microscope (Nikon Eclipse E600) using a 100
objective.
2.7. Ultrastructural immunocytochemistry
Epimastigotes of Dm28c strain were washed in 0.1 M phosphate
buffer (pH 7.2) and ﬁxed for 30 min with 2.5% glutaraldehyde in
0.1 M phosphate buffer. The cells were then washed twice with
0.1 M phosphate buffer and postﬁxed for 15 min with 1% osmium
tetroxide/0.8% potassium ferricyanide/5 mM CaCl2 in 0.1 M caco-
dylate buffer, pH 7.2 (Meirelles and Soares, 2001). Cells were rinsed
in this ﬁxing buffer and then dehydrated in graded acetone, inﬁl-
trated overnight in a (1:1) 100% acetone/PolyBed 812 mixture,
and embedded for 72 h at 60 C in PolyBed 812 (PolySciences, War-
rington, PA, USA) resin. Ultrathin sections were obtained with a
Leica ultramicrotome (Reichert Ultracuts) and grids containing
the sections were incubated with 50 mM NH4Cl for 30 min. They
were incubated with blocking solution (3% BSA, 0.5% teleostean
gelatin diluted in PBS, pH 8.0) for 30 min, followed by incubation
with anti-HslV antiserum diluted 1:50 in blocking solution for
1 h. The grids were then incubated for 30 min with gold-labeled
goat anti-mouse IgG (Sigma) diluted 1:200 in blocking solution,
washed and stained with uranyl acetate and lead citrate for further
observation in transmission electron microscope. For control as-
says, incubation with the primary antiserum was omitted.
2.8. Statistical analysis
Relative expression by Western blot was compared by one-way
analysis of variance (ANOVA) with a post hoc Tukey test or Stu-
dent’s t-test. A p value < 0.05 was considered statistically signiﬁ-
cant. Statistical analysis was performed by the program PRISM
(GraphPad Prism 5).Fig. 1. Immunoprecipitation of HslVU complex. Protein extracts from epimastigotes
were used in an immunoprecipitation assay. 1. Eluate from HslV immunoprecip-
itation revealed with anti-HslU. 2. Eluate from HslV immunoprecipitation revealed
with anti-HslV. 3. Eluate from pre-immune immunoprecipitation revealed with
anti-HslU. 4. Eluate from pre-immune immunoprecipitation revealed with anti-
HsIV.3. Results
3.1. Co-precipitation of HslVU complex components
The recombinants TcHslV and TcHslU were expressed in an
insoluble fraction and showed bands corresponding to the theoret-
ical mass predicted to both proteins (predicted mass was calcu-
lated according to the size of the sequence recovered from the
GeneDB database). The recombinant proteins identities were ana-
lyzed by mass spectrometry. The data were submitted to the
search for identity in the database of T. cruzi GeneDB using the soft-
ware MASCOT. The amino acids of the TcHslV found by mass spec-
trometry covered 66% and TcHslU covered 54% of the predicted T.
cruzi HslV and HslU proteins, respectively (Figs. S1 and S2).To demonstrate that the protease exists as a HsIVU complex in
T. cruzi, an immunoprecipitation assay was performed. An epimas-
tigote protein extract from T. cruzi Y strain was used in this exper-
iment. Fig. 1 shows that by using antibodies raised against HslV it
is possible to coimmunoprecipitate HslU.
3.2. HslV localization in T. cruzi
To study the intracellular localization of HslV in T. cruziwe used
speciﬁc antibodies to perform immunolocalization and immunocy-
tochemistry assays. Immunolocalization was carried out using T.
cruzi epimastigotes from Y strain (Fig. 2A) and Dm28c strain
(Fig. 2B). The results of the immunolocalization revealed a distribu-
tion in the cytoplasm and a predominant kinetoplast localization in
both strains (Fig. 2). Immunocytochemistry was performed with
Dm28c strain and the results obtained conﬁrmed HslV localization
in the kinetoplast of T. cruzi (Fig. 3).
3.3. HslV and 20S proteasome are differentially expressed in T. cruzi
strains
To look for possible differences in HslV expression between dif-
ferent T. cruzi strains, we carried out experiments with three T. cru-
zi strains. As shown in Fig. 4A, HslV expression of Y strain was 2.5
times more abundant than HslV expression in Be-62 and Be-78
strains. In Fig. 4B we show proteasome levels estimated by the lev-
els of a7 proteasome subunit. The Y strain showed proteasome lev-
els three times lower than Be-62 and one time lower than Be-78.
The relationship between the expressions of HslV and the 20S
proteasome in epimastigotes of T. cruzi is shown in Fig. 5. The
Be-62 strain showed 20S proteasome expression 6.5 times higher
than HslV, whereas Be-78 showed an expression of 20S protea-
some about 4.5 times higher than HslV. The Y strain had no differ-
ence between the levels of 20S proteasome and HslV. This
experiment shows that HslV and 20S proteasome are differently
expressed between the strains studied.
3.4. Proteasome inhibitor PSI effect on the HslV and proteasome
expressions
To investigate whether a proteasome inhibitor could modulate
HslV and proteasome expressions, epimastigotes from T. cruziwere
grown in the presence of PSI as described in Section 2.1 and the
levels detected as described above.
In Fig. 6A we show that the PSI affected HslV expression only in
the Be-62 strain with an increase of about three times of this
Fig. 2. Epimastigotes parasites from Dm28c (A) and Y (B) strains were labeled with antibodies speciﬁc to the HslV. (a) Phase contrast. (b and e) Label with HslV and
predominant kinetoplast localization was observed. (c and f) DAPI was used to stain nuclei (asterisk) and kinetoplast (arrow). (d and g) Merged images suggesting co-
localization of HslV with kinetoplast (asterisk) of epimastigotes. Bars = 10 lm.
Fig. 3. Ultrastructural localization of HslV by transmission electron microscopy in T. cruzi: (A) Figure Bar: 50 nm. K: kinetoplast; N: nucleus. (B) HslV was present in
kinetoplast of epimastigotes (arrow). Bar: 200 nm.
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fect on the 20S proteasome, with an expression about twofold low-
er in parasites grown in the presence of PSI. We can also observe in
Fig. 6B that the PSI affected the expression of the 20S proteasome
in the Y strain increasing its amount in approximately four times.
The Be-78 strain showed no signiﬁcant changes in both proteases
expression. Taken together, these results suggest that the protea-
some inhibitor is able to modulate HslV and 20S proteasome
expression.
4. Discussion
Until recently it was believed that each biological kingdom had
a speciﬁc high molecular weight ATP-dependent protesase.
Eukaryotes and Archaea have the 20S proteasome, whereas in
bacteria HslVU prevails. However, in the genome of the protists
Leishimania major, T. brucei, T. cruzi, P. falciparum and Plasmodiumyoelii sequences were found for both types of proteasomes (Couvr-
eur et al., 2002; Gille et al., 2003).
The contribution of proteasomes to the differentiation process
of T. cruzi was previously demonstrated using a proteasome inhib-
itor, like lactacystin, that could prevent the differentiation of try-
pomastigotes to amastigotes, and the intracellular differentiation
of amastigotes to trypomastigotes and T. cruzi metacyclogenesis
(De Diego et al., 2001; Cardoso et al., 2008). However, the role of
HslVU complex in T. cruzi biology is unknown. In this work we re-
port the expression proﬁle and subcellular localization of HslV
from T. cruzi.
Initially, we demonstrate that the protease HslV and ATPase
HslU form a complex, as shown in Fig. 1. It has been reported that
HslU is important to HslV activities (Yoo et al., 1996). The HslV-
HslU interaction is regulated by several factors. Seong et al.
(2002) showed that HslV-HslU interaction is dependent on the C-
terminal tail of HslU, which is inserted into the HslV–HslV
Fig. 4. Western blot analysis of HslV and 20S proteasome using crude extracts from
three different T. cruzi strains. Densitometric analysis of the immunoblotting signal
to HslV and a7 proteasome were normalized with the immunoblotting signal to
HSP70 using Bio-rad Quantity One software. This assay used data of three biological
samples. (A) Relative expression of HslV represented on the bar graph was shown in
the upper panel and Western blot was shown in the lower panel. Statistic
differences between T. cruzi strains are shown by the letters: (a) different from Y
and (b) different from Be-62, Be-78. (B) Relative expression of 20S proteasome
represented on the bar graph was shown in the upper panel and Western blot was
shown in the lower panel. Statistic differences between T. cruzi strains are shown by
the letters: (a) different from Be-78 and Y; (b) different from Be-62 and Y; (c)
different from Be-62, Be-78 (one-way variance analysis followed by Tukey pairwise
comparison p < 0.05).
Fig. 5. Comparison of relative expression between HslV and 20S proteasome of
three T. cruzi strains. Densitometric analysis of the immunoblotting signal to HslV
and a7 proteasome were normalized with the immunoblotting signal to HSP70
using Bio-rad Quantity One software and the results were compared with each
other. This assay used data of three biological samples. Statistical analysis were
done using Student’s t-test with p < 0.05. ⁄Indicate statistical different expression
levels between HslV and 20S proteasome in the same strains.
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the allosteric activation of HslV by HslU.
The localization of T. cruziHslVwas performed by an immunolo-
calization assay.We found that T. cruziHslV is predominantly local-
ized in the kinetoplast with a distribution in the cytoplasm (Fig. 2).
To conﬁrm these results we performed an ultrastructural immuno-
cytochemistry assay and the results showed a location only in the
kinetoplast (Fig. 3). This result suggests that the HslV found in the
cytoplasm through the immunolocalization assay could be proteins
that were being transported to the mitochondria. Tschan et al.
(2010) used bioinformatics analysis to predict HslV localization of
many organisms and showed that T. cruzi HslV was predicted to
be targeted to the mitochondrion with high probability. InP. falciparum HslV is expressed as a pro-protein and has to be pro-
cessed for its import to mitochondria. When the mitochondrial
transport protein was impaired, there was pro-HslV accumulation
and a decrease in the amount of mature HsIV (Tschan et al.,
2010). Li et al. (2008) demonstrated T. brucei HslVU localization in
the mitochondria and its important role in replication and segrega-
tion of kDNA.
It has also been shown that the proteasome has been involved
in maintaining mitochondrial function. Proteasome inhibition from
Saccharomyces cerevisae (Malc et al., 2009), neural cells (Sullivan
et al., 2004) and human ﬁbroblasts (Torres and Perez, 2008) in-
duced a reduction in mitochondrial respiratory capacity and an in-
crease of reactive oxygen species concentrations. These evidences
suggested that HslV/20S proteasome could have a similar function
in T. cruzi mitochondria. This hypothesis is corroborated by the
demonstration of proteasome accumulation throughout the T. cruzi
body or accumulation in organelles such as kinetoplast and nu-
cleus in all development stages and during metacylogenesis (Car-
doso et al., 2011; Gutiérrez et al., 2009).
Because both HslV and proteasome are localized in the kineto-
plast and probably play important roles in this organelle, we inves-
tigated whether both threonine protease were differentially
expressed in epimastigotes from three T. cruzi strains. Our results
show protein levels variation of both HslV and 20S proteasome be-
tween the T. cruzi strains studied (Fig. 4). The co-expression of
HslV/20S proteasome was analyzed during the in vitro T. cruzi
metacylogenesis and showed similar levels of expression (personal
communication). Interestingly, in P. falciparum, HslV expression
was stage-speciﬁc (Mordmüller et al., 2006). Differences in HslV
and 20S porteasome expression patterns between different T. cruzi
strains could be related with the different genotypes and pheno-
types and differences in biological (Lana and Chiari, 1986) and bio-
chemical proﬁles (Lana et al., 1996) of different strains of T. cruzi.
The correlation between genetic diversity and pathogenicity of T.
cruzi is based on the assumption that the heterogeneity of a strain
and multiclonal factors are responsible for the different tissue tro-
pisms and thus by the different clinical manifestations of the dis-
ease. Biochemical and genomic T. cruzi are revealing a variety of
genes and functions that contribute independently to virulence
(Pereyra, 1996; Basombrio et al., 1996). Therefore, variation in
the expression proﬁle of HslV and proteasome 20S may suggest
involvement of both proteases in the biological processes like vir-
ulence, tissue tropism and parasite-host interaction.
Although HslV has low similarity to proteasome beta catalytic
subunitis, the threonine residues of the catalytic site are conserved
in both proteases (Couvreu et al., 2002), and HslV is also inhibited
by classical proteasome inhibitors, like MG-132 and lactacistin
(Ramasamy et al., 2007; Rohrwild et al., 1996). Unfortunately, we
could only obtain the T. cruzi recombinant protein HslV in an insol-
uble and inactive form. Therefore, we could not perform tests to as-
sess the kinetics of the HslV proteolysis in vitro. However, we
investigated whether a proteasome inhibitor could have a modula-
tory effect on the expression of both the 20S proteasome and HslV.
It was found that PSI affects the expression levels of HslV and
20S proteasome heterogeneously in the T. cruzi strains studied
(Fig. 6), suggesting that the regulation of these proteases expres-
sion may be strains speciﬁc, under stress. The Y strain showed an
increase in proteasome expression levels and it could be a mecha-
nism of self regulation by the proteasome. The inhibition of this
protease could lead to an increase in its expression to compensate
for the loss of functional proteasomes. This could also explain the
increase in expression levels of HslV in Be-62 strain, with HslV per-
forming the proteasome function. These results are corroborated
by Fuchs et al. (2008), Meiners et al. (2003), Wojcik and DeMartino
(2002) that demonstrate a direct effect of a proteosome inhibitor
on the regulation of proteasome levels in several experimental
Fig. 6. Relative expression of HslV and 20S proteasome using crude extracts from three different T. cruzi strains grown without PSI and grown under 30 nM PSI. Densitometric
analysis of the immunoblotting signal (data not shown) to HslV and a7 proteasome subunit were normalized with the immunoblotting signal to HSP70 using Bio-rad
Quantity One software. This assay used data of three biological samples. Relative expression of HslV (A) and 20S proteasome (B) were represented on the bar graph. ⁄Indicate
statistical different expression levels of HslV and 20S proteasome in strains grown without or under 30nM PSI (one-way variance analysis followed by Tukey pairwise
comparison p < 0.05).
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proteasome inhibitor MG-132 (10 nM) increased the catalytic
activities of the proteasome accompanied by a modest increase
in the expression of its subunits in cultured neocortical neurons
of mice treated for 18 h.
In conclusion, we report that HslV and HslU form a complex and
its localization is in the kinetoplast. We also show a differential
expression of HslV and 20S proteasome between T. cruzi strains,
corroborated by the high genetic diversity observed in different
strains of this parasite. We also demonstrate the coexistence of
the HslV and 20S proteasome in T. cruzi reinforcing the idea that
non-lysosomal degradation pathways have an important role in
regulating the proteome in this parasite. Future experiments using
knockout parasites will be developed to establish the exact func-
tion and natural target of the HslVU protease in T. cruzi.
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